Effect of Siddharthakadi Basti in Retained products of conception

An Exploratory Study To Evaluate The Effect of Siddharthakadi Basti in Retained Products of Conception - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064729

Enrollment

Registered

2024-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O73- Retained placenta and membranes, without hemorrhage

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married Female Patient of age 18-45 years old. 2. Thick irregular endometrium on trans-vaginal sonography suggesting RPOC. (ICD NO.-O03.4)

Exclusion criteria

Exclusion criteria: 1. Patients with untreated urogenital infections. 2. Patients suffering from any chronic debilitating disease like diabetes mellitus hypertension, sexually transmitted disease, hepatitis B. 3. Patients not willing to be included in the study.

Design outcomes

Primary

Measure	Time frame
Expulsion of retained products of conceptionTimepoint: Maximum 8 days of drug intervention FOLLOW-UP Patient will be monitored daily during basti and will be advised for repeat ultrasonography (USG) after treatment.	—

Secondary

Measure	Time frame
1. Stops P/V Bleeding 2. Relief in abdominal pain Timepoint: Maximum 8 days of drug intervention FOLLOW-UP Patient will be monitored daily during basti and will be advised for repeat ultrasonography (USG) after treatment.	—

Countries

India

Contacts

Public ContactDr AVANIKA GUNJIYAL

All India Institute of Ayurveda

drmeenakshipathak@gmail.com9984549998

Outcome results